Rediff Growth for Q1 impacted by core pharma business, says #GlaxoSmithKline-Pharmaceuticals-Ltd
(CNBC TV18) #money
Rediff #Earnings
: #GlaxoSmithKline-Pharmaceuticals-Ltd
Q1 net sales at Rs 632.1 crore versus Rs 623 crore (YoY). (CNBC TV18) #money
Rediff #Earnings
: #GlaxoSmithKline-Pharmaceuticals-Ltd
Q1 net profit at Rs 169 crore versus Rs 123 crore (YoY). (CNBC TV18) #money
earninhiddengemsdotcom First try urself,and then believe in http://rediff.ly/1qfhu Get Ready for Amazing profit #GlaxoSmithKline-Pharmaceuticals-Ltd
earninhiddengemsdotcomgood returns even in down & up market.
sorav Buy ..bonus coming #GlaxoSmithKline-Pharmaceuticals-Ltd
#money
soravNO BONUS, HOWEVER GOOD DIVIDEND PAYOUT: RECOMMEND EXIT AFTER PAYOUT
sorav Buy intraday tgt of 2250 #GlaxoSmithKline-Pharmaceuticals-Ltd
#money
devarsh tgt : 2255 ssl : 1912 #GlaxoSmithKline-Pharmaceuticals-Ltd
#money
Rediff #GlaxoSmithKline-Pharmaceuticals-Ltd
: We saw double digit growth across verticals. (ET Now) #money
samir cNot sure abt 2800 but definitely 2500
sorav Why a recent rally...Is company going to declare bonus #GlaxoSmithKline-Pharmaceuticals-Ltd
#money
sorav Buy - Target of Rs 2800 #GlaxoSmithKline-Pharmaceuticals-Ltd
#money